Cargando…
Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway
While Bufalin restrains primary tumorigenesis, the role of Bufalin in cervical cancer remains unclear. Here, we show that Bufalin can inhibit cervical cancer cell proliferation, block cell cycle in G2/M phase, induce cellular apoptosis and reduce cell metastasis through stimulation of p21(waf/cip1),...
Autores principales: | Liu, Fei, Tong, Duo, Li, Haoran, Liu, Mingming, Li, Jiajia, Wang, Ziliang, Cheng, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891012/ https://www.ncbi.nlm.nih.gov/pubmed/26758421 http://dx.doi.org/10.18632/oncotarget.6840 |
Ejemplares similares
-
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017) -
Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
por: Yuan, Jiani, et al.
Publicado: (2019) -
RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis
por: Zhang, Wen, et al.
Publicado: (2015) -
The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
por: Jiang, Han-yu, et al.
Publicado: (2022) -
Surfactant Assisted Rapid-Release Liposomal Strategies Enhance the Antitumor Efficiency of Bufalin Derivative and Reduce Cardiotoxicity
por: Gao, Lina, et al.
Publicado: (2021)